Silas Holland
Company: The AMR Action Fund & Merck
Job title: Head of External Affairs (Interim) & Director of Global Public Policy
Seminars:
Q&A/Discussion 10:15 am
day: Day One
AMR Action Fund: Strengthening & Accelerating Antibiotic Development 9:00 am
Due to a broken market, many promising antibiotics in the early-stage pipeline may never reach patients because of a lack of investors in clinical development More than 20 pharmaceutical companies have launched the US$1B AMR Action Fund that will make investments in biotechs to bring 2-4 new antibiotics to patients by 2030 Urgent policy action…Read more
day: Day One